Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patty J Nelemans

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
JAMA Dermatology|April 27, 2022
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical TrialShima Ahmady, Maud H E Jansen, Patty J Nelemans, et al.
The Lancet. Oncology|July 14, 2022
Optical coherence tomography versus punch biopsy for diagnosis of basal cell carcinoma: a multicentre, randomised, non-inferiority trialFieke Adan, Patty J Nelemans, Brigitte A B Essers, et al.
The Journal of Investigative Dermatology|October 19, 2017
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell CarcinomaMaud H E Jansen, Klara Mosterd, Aimee H M M Arits, et al.
Annals of Surgical Oncology|July 23, 2015
Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving TreatmentMonique Maas, Doenja M J Lambregts, Patty J Nelemans, et al.
The New England Journal of Medicine|March 12, 2019
Randomized Trial of Four Treatment Approaches for Actinic KeratosisMaud H E Jansen, Janneke P H M Kessels, Patty J Nelemans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancerMonique Maas, Regina G H Beets-Tan, Doenja M J Lambregts, et al.
Clinical Breast Cancer|February 20, 2014
A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancerRobert-Jan Schipper, Martine Moossdorff, Patty J Nelemans, et al.
Patient Education and Counseling|July 24, 2023
Effectiveness of a patient decision aid for patients with superficial basal cell carcinoma: A pre- and post-implementation studyLieke C J van Delft, Brigitte A B Essers, Patty J Nelemans, et al.
The Lancet. Oncology|August 10, 2010
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient dataMonique Maas, Patty J Nelemans, Vincenzo Valentini, et al.
Breast (Edinburgh, Scotland)|February 8, 2026
Impact of axillary disease extent defined by baseline <sup>18</sup>F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancerCornelis M de Mooij, Janine M Simons, Florien J G van Amstel, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
JAMA Dermatology|April 27, 2022
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical TrialShima Ahmady, Maud H E Jansen, Patty J Nelemans, et al.
The Lancet. Oncology|July 14, 2022
Optical coherence tomography versus punch biopsy for diagnosis of basal cell carcinoma: a multicentre, randomised, non-inferiority trialFieke Adan, Patty J Nelemans, Brigitte A B Essers, et al.
The Journal of Investigative Dermatology|October 19, 2017
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell CarcinomaMaud H E Jansen, Klara Mosterd, Aimee H M M Arits, et al.
Annals of Surgical Oncology|July 23, 2015
Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving TreatmentMonique Maas, Doenja M J Lambregts, Patty J Nelemans, et al.
The New England Journal of Medicine|March 12, 2019
Randomized Trial of Four Treatment Approaches for Actinic KeratosisMaud H E Jansen, Janneke P H M Kessels, Patty J Nelemans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancerMonique Maas, Regina G H Beets-Tan, Doenja M J Lambregts, et al.
Clinical Breast Cancer|February 20, 2014
A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancerRobert-Jan Schipper, Martine Moossdorff, Patty J Nelemans, et al.
Patient Education and Counseling|July 24, 2023
Effectiveness of a patient decision aid for patients with superficial basal cell carcinoma: A pre- and post-implementation studyLieke C J van Delft, Brigitte A B Essers, Patty J Nelemans, et al.
The Lancet. Oncology|August 10, 2010
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient dataMonique Maas, Patty J Nelemans, Vincenzo Valentini, et al.
Breast (Edinburgh, Scotland)|February 8, 2026
Impact of axillary disease extent defined by baseline <sup>18</sup>F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancerCornelis M de Mooij, Janine M Simons, Florien J G van Amstel, et al.
Pageof 11